 Connection
Erin Schenk to Molecular Targeted Therapy
This is a "connection" page, showing publications Erin Schenk has written about Molecular Targeted Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.107 |
|
|
|
-
Florez N, Patel SP, Salgia R, Sands J, Schenk EL, Shum E, Aldea M, Bestvina CM, Donington J, Garcia CA, Nieva J, Gandara DR, Halmos B, Hirsch FR, Le X, Lee P, Malhotra J, Patil T, Peters S, Riess JW, Rotow J, Rous FA, Sabari J, Sen T, Singhi EK, Velázquez AI, Wakelee HA, Kim ES. Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025. Cancer. 2026 Oct 01; 132(19):e70633.
Score: 0.049
-
Bullock BL, Kimball AK, Poczobutt JM, Neuwelt AJ, Li HY, Johnson AM, Kwak JW, Kleczko EK, Kaspar RE, Wagner EK, Hopp K, Schenk EL, Weiser-Evans MC, Clambey ET, Nemenoff RA. Tumor-intrinsic response to IFN? shapes the tumor microenvironment and anti-PD-1 response in NSCLC. Life Sci Alliance. 2019 06; 2(3).
Score: 0.029
-
Bunn PA, Schenk E, Pacheco J, Dimou A. New Developments in Neoadjuvant Therapy for Lung Cancer. Oncology (Williston Park). 2019 Mar 13; 33(3):101-6, 109.
Score: 0.029
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|